At 11.5% CAGR, Asia Pacific Medical Writing Market is Projected to be Worth US$ 2,565.87 Million by 2031 says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific medical writing market was valued at US$ 1,076.74 million in 2023 and is expected to reach US$ 2,565.87 million by 2031, registering a CAGR of 11.5% from 2023 to 2031. High preference for CROs and implementation of tools and artificial intelligence in medical writing are among the critical factors attributed to drive the Asia Pacific medical writing market.

The quality of documents that medical writers produce in a CRO is considered to be better in comparison with BPO companies. The medical writings of CRO have in-depth scientific data. They are high scorers in terms of formatting, presentation, and adherence to guidelines. Besides, the documents presented by CROs are delivered on time as they have strict deadlines.

CROs are tech-savvy, which is another reason why CROs are preferred for outsourcing medical writing tasks. Major CROs enjoy the merits of a wide geographic reach. For instance, Makro Care has a presence across various cities in Asian countries. This, in turn, provides a comfort level to the functional teams of pharmaceutical and biotechnological companies. Due to all such essential advantages, together with technical expertise, CROs turn out to be the first choice for the outsourcing of medical writing projects.

On the contrary, insufficient skilled medical writers hamper the growth of Asia Pacific Medical Writing Market.

Based on type, the Asia Pacific medical writing market is segmented into clinical writing, regulatory writing, scientific writing, and others. The clinical writing segment held 44.1% market share in 2023, amassing US$ 474.86 million. It is projected to garner US$ 1,172.77 million by 2031 to register 12.0% CAGR during 2023–2031.

By application, the Asia Pacific medical writing market is segmented into medical journalism, medical education, and medico marketing. The medical journalism segment held 60.5% share of the Asia Pacific medical writing market in 2023, amassing US$ 651.24 million. It is projected to garner US$ 1,574.91 million by 2031 to expand at 11.7% CAGR from 2023 to 2031.

Based on end user, the Asia Pacific medical writing market is bifurcated into pharmaceutical and biotechnology companies, and contract research organizations. The pharmaceutical and biotechnology companies segment held 70.5% market share in 2023, amassing US$ 759.26 million. It is projected to garner US$ 1,880.42 million by 2031 to register 12.0% CAGR during 2023–2031.

Based on country, the Asia Pacific medical writing market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.7% share of Asia Pacific medical writing market in 2023. It was assessed at US$ 297.89 million in 2023 and is likely to hit US$ 727.22 million by 2031, registering a CAGR of 11.8% during 2023 to 2031.

Key players operating in the medical writing market are Cactus Communications, Parexel International Corp, Certara Inc, Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences, among others .

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com